Concepedia

Kenji Hirotani

KH

Statistics

Publications

22

Citations

1.5K

H-Index

20

Active since

1989

Affiliations

Daiichi-Sankyo (Japan)(Current)

Kindai University

Daiichi University of Pharmacy

Daiichi Sankyo (Germany)

Kindai University Hospital

Kenji Hirotani is an author at Daiichi-Sankyo (Japan) specializing in pharmacology, medicine, and oncology.

Publications per year

1989–2021

22

Publications

22

A Novel HER3-Targeting Antibody–Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization

Yuuri Hashimoto, Kumiko Koyama, Yasuki Kamai et al. · Clinical Cancer Research · 2019 · 174 citations

, , +15

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

Kimio Yonesaka, Koji Haratani, Shiki Takamura et al. · Clinical Cancer Research · 2018 · 169 citations

, , +17

A highly potent antiangiogenic activity of retinoids

Tsutomu Oikawa, Kenji Hirotani, Osamu Nakamura et al. · Cancer Letters · 1989 · 143 citations

, , +7

Inhibition of angiogenesis by vitamin D3 analogues

Tsutomu Oikawa, Kenji Hirotani, Hiroyuki Ogasawara et al. · European Journal of Pharmacology · 1990 · 120 citations

, , +10

An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC

Kimio Yonesaka, Naoki Takegawa, Satomi Watanabe et al. · Oncogene · 2018 · 101 citations

, , +14

1–5 of 22